Scinai Immunotherapeutics Ltd.
Dual-model biopharma: developing NanoAbs for I&I and offering CDMO services.
SCNI | US
Overview
Corporate Details
- ISIN(s):
- US09073Q3039 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- JERUSALEM BIOPARK, 2ND FLOOR, 0 JERUSALEM
- Website:
- https://www.scinai.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Scinai Immunotherapeutics is a biopharmaceutical company with a dual business model focused on inflammation and immunology (I&I). The company develops a proprietary pipeline of biological products, including alpaca-derived nanosized antibodies (NanoAbs) for autoimmune and infectious diseases, in collaboration with institutions like the Max Planck Institute. Additionally, its Scinai Bio-services business unit operates as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive services to other pharmaceutical and biotech companies. These services span process and analytical development, scale-up, and cGMP manufacturing for nonclinical and clinical studies from its state-of-the-art facility.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Scinai Immunotherapeutics Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Scinai Immunotherapeutics Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Scinai Immunotherapeutics Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
